ET Phyllin (100 mg): Each sugar-coated, immediate release tablet contains Etofylline IP 77 mg + Theophylline IP 23 mg.
ET Phyllin Retard (150 mg): Each sugar-coated, sustained release tablet contains Etofylline IP 115 mg + Theophylline IP 35 mg.
ET Phylline Retard Plus (300 mg): Each sugar-coated, sustained release tablet contains Etofylline BP 231 mg + Theophylline BP 69 mg.
Usage: Selected maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD), when prescribed.
Category: Anti Allergic Drugs
Therapeutic Category: Antiasthmatic / Methylxanthine Bronchodilator
SKU: Etofylline Theophylline Tablets
Categories: Pharmaceutical Exporter India, Pharmaceutical Formulations India, WHO GMP Certified Formulations
Etofylline Theophylline Tablets is listed in our pharmaceutical product portfolio for business-to-business enquiries. Product-specific formulation details, available strengths, dosage form, pack configuration and supply terms should be confirmed against the current product specification before ordering.
For distributor, wholesaler, hospital procurement and export enquiries, please request the applicable product specifications, batch documentation, shelf-life information, packaging options and regulatory documents. Availability and documentation depend on the product and destination market.
Manufactured by: Healthy Life Pharma Pvt. Ltd. (WHO-GMP Certified)
Exported by: Healthy Inc (Star Export House)
Healthy Life Pharma Pvt. Ltd. offers Etofylline and Theophylline combination tablets for markets where these products are approved. Both ingredients are methylxanthine bronchodilators. Oral methylxanthines are not usually preferred first-line maintenance therapy for asthma or COPD when suitable inhaled treatments are available, because theophylline has a narrow therapeutic index and important interactions. These tablets are not rescue treatment for an acute asthma attack.
| Presentation | Total Strength | Composition per Tablet | Release Form |
|---|---|---|---|
| ET Phyllin | 100 mg | Etofylline IP 77 mg + Theophylline IP 23 mg | Sugar-coated, immediate release |
| ET Phyllin Retard | 150 mg | Etofylline IP 115 mg + Theophylline IP 35 mg | Sugar-coated, sustained release |
| ET Phylline Retard Plus | 300 mg | Etofylline BP 231 mg + Theophylline BP 69 mg | Sugar-coated, sustained release |
Therapeutic class: Methylxanthine bronchodilator. Packaging, shelf life and storage: As supported by the registered product specifications and stability data.
Immediate-release and sustained-release formulations are separate products with distinct dissolution specifications. Sustained-release tablets use a validated release-controlling formulation; the exact release duration and dosing interval depend on the approved product. Tablet uniformity and release testing are especially important because of theophylline's narrow therapeutic index. Coating, packaging and process controls are determined by the registered formula.
Etofylline and theophylline are methylxanthines with bronchodilator activity. Theophylline has multiple mechanisms, including phosphodiesterase inhibition and adenosine-receptor antagonism. Selected patients with asthma or COPD may receive an oral methylxanthine as part of an individualized regimen, but inhaled therapies are generally preferred in contemporary treatment guidelines. This combination does not replace inhaled rescue medication.
Healthy Inc coordinates export inquiries. CTD/ACTD dossiers, certificates of analysis and other regulatory documents may be provided where available for the relevant registered formulation and destination market. Brand interchangeability or bioequivalence should not be assumed without supporting evidence.
Who manufactures these tablets? Healthy Life Pharma Pvt. Ltd., India.
Are these the same as Deriphyllin? Deriphyllin is a branded combination; comparable ingredient names or ratios do not establish regulatory equivalence or interchangeability.
Can I drink coffee? Excess caffeine can increase stimulant adverse effects such as palpitations, tremor and insomnia.
Does smoking matter? Tobacco smoking can increase theophylline clearance. Starting or stopping smoking can alter blood levels and may require clinician-supervised adjustment and monitoring.
Dose and schedule must be individualized according to the exact immediate-release or sustained-release product, age, liver function, smoking status, interacting medicines and clinical response. Theophylline serum concentration monitoring may be necessary. Do not crush or chew sustained-release tablets unless the specific product instructions explicitly permit it. Follow the registered label for food instructions.
Store as stated on the approved pack label, protected from excess moisture and heat. Keep in original packaging and out of reach of children.